Icosavax’s $67.8 Million Registered Direct Offering of Common Stock

Latham & Watkins advised Icosavax on the offering.Icosavax, Inc. (Nasdaq: ICVX) has announced that it has entered into a securities purchase agreement with investors in a registered…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now